Research To Practice | Oncology Videos

Featuring perspectives from Dr Komal Jhaveri, including the following topics: •       Case: A premenopausal woman in her early 40s with a 5.8-cm, ER/PR-positive, HER2-negative infiltrating lobular carcinoma and microscopic sentinel node involvement — Arielle Heeke, MD (11:58) •       Case: A premenopausal woman in her early 40s with a 3.1-cm ER/PR-positive, HER2-negative localized invasive ductal...

Featuring perspectives from Drs Farrukh Awan and Kelly Rogers, including the following topics: •       Case: A woman in her early 90s with underlying chronic obstructive pulmonary disease was observed for 20 years for chronic lymphocytic leukemia (CLL) before initiating treatment with acalabrutinib and quickly develops fatigue, headache and diarrhea — Erik Rupard, MD (16:56) •       Case: A frail...

Featuring perspectives from Drs Tanios Bekaii-Saab, Scott Kopetz, and John Strickler and Prof Eric Van Cutsem, moderated by Dr Kristen Ciombor, including the following topics: •       Integration of Therapies Targeting BRAF and HER2 in Metastatic Colorectal Cancer (mCRC) — Dr Strickler o   Introduction (0:00) o   Case: A man in his early 40s presenting with microsatellite-stable (MSS) rectal cance...

Featuring perspectives from Dr Bob Li, including the following topics: •       Evolution of targeted therapy for HER2-altered non-small cell lung cancer (NSCLC) (0:00) •       Incidence and management of HER2 amplifications and mutations in NSCLC (10:45) •       Role of ErbB/HER protein family biology in lung cancer (19:03) •       Current and emerging roles of antibody-drug conjugates in lung can...

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hodgkin and Non-Hodgkin Lymphomas — Faculty Presentation 2: Follicular Lymphoma and Mantle Cell Lymphoma — Dr Laurie Sehn CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hodgkin and Non-Hodgkin Lymphomas — Faculty Presentation 1: Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma — Dr Christopher Flowers CME information and select publications

Featuring perspectives from Drs Christopher Flowers and Laurie Sehn, including the following topics: •       Introduction (0:00) •       Treatment for Diffuse Large B-Cell Lymphoma (7:45) •       Management of Hodgkin Lymphoma (35:33) •       Follicular Lymphoma (41:57) •       Caring for Patients with Mantle Cell Lymphoma (51:38) CME information and select publications

Featuring perspectives from Drs Jonathan Strosberg and Lori Wirth, including the following topics: Nontargeted Treatment for Thyroid Cancer     Introduction (0:00) Case: A woman in her late 60s with poorly differentiated thyroid cancer initially treated with lenvatinib – Dr Wirth (6:05) NTRK Fusions in Thyroid Cancer   Case: A woman in her early 60s with metastatic papillary thyroid cancer with an...

Featuring perspectives from Dr Noopur Raje, including the following topics: •       Introduction (0:00) •       Case: A man in his early 80s who presents with renal failure (creatine = 7) and standard-risk multiple myeloma (MM) — Swati Vishwanathan, MD (14:22) •       Case: A man in his late 60s with a large sternal plasmacytoma — Warren S Brenner, MD (20:35) •       Case: A man in his early 60s w...

Featuring a slide presentation and related discussion from Dr Edward Garon, including the following topics: • Immune checkpoint inhibitor therapy for treatment-naïve advanced non-small cell lung cancer (NSCLC) without an actionable mutation (0:00) • Duration of immunotherapy in the frontline setting for NSCLC with no targetable mutation (13:43) • New treatment strategies for relapsed or refractory...

Featuring an interview with Dr Edward Garon, including the following topics: Treatment of non-small cell lung cancer (NSCLC) today versus prior to the availability of immune checkpoint inhibitors (0:00) Current and emerging roles of antibody-drug conjugates in NSCLC (3:30) Optimal workup for patients presenting with metastatic NSCLC; role of biomarker assessment (5:02) Considerations for the addit...

Featuring perspectives from Dr Srdan Verstovsek, including the following topics: Overview of current issues in the management of myeloproliferative neoplasms (MPN) (0:00) Treatment strategies for patients with myelofibrosis (MF) progressing after ruxolitinib (14:46) Correlation of molecular characterization and response to ruxolitinib in patients with MF (23:57) Rationale for and efficacy with com...

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology — Faculty Presentation 2: Endometrial and Cervical Cancer — Dr Krishnansu Tewari CME information and select publications

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology — Faculty Presentation 1: Ovarian Cancer — Dr Kathleen Moore CME information and select publications

Featuring perspectives from Drs Michael Birrer and Kathleen Moore, including the following topics: Gynecologic Oncology   Introduction (0:00) Ovarian Cancer    PARP inhibitors as primary maintenance (8:11) PARP inhibitors for recurrent and metastatic disease (19:04) Antibody-drug conjugates: Mirvetuximab soravtansine; upifitamab rilsodotin (31:39) Endometrial Cancer   Immunotherapy for metastatic...

Featuring a slide presentation and related discussion from Dr Gilles Salles, including the following topics: Recent data with polatuzumab vedotin/bendamustine/rituximab for relapsed/refractory diffuse large B-cell lymphoma (DLBCL) (0:00) Available data from trials evaluating tafasitamab/lenalidomide, loncastuximab tesirine and selinexor for DLBCL (12:57) Current and future roles of chimeric antige...

Featuring an interview with Dr Gilles Salles, including the following topics: Biology underlying B-cell lymphomas, role of Bruton tyrosine kinase (BTK) inhibitors in lymphomas and reason for cure in diffuse large B-cell lymphoma (DLBCL) versus indolent lymphomas (0:00) Efficacy, tolerability and optimal sequencing of selinexor, polatuzumab vedotin/bendamustine/rituximab, tafasitamab/lenalidomide a...

Featuring perspectives from Dr Richard Stone, including the following topics: Current and future trends in the care of patients with acute myeloid leukemia (AML) (0:00) Management of AML with IDH1/2 and FLT3 mutations (17:28) Advances in the treatment of high-risk AML (29:42) Emerging data with novel therapies for AML with targetable mutations (36:53) Hematopoietic stem cell transplantation as a t...

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma — Faculty Presentation 2: Chimeric Antigen Receptor T-Cell Therapy, Bispecific Antibodies and Other Novel Approaches for MM — Dr Ajay Nooka CME information and select publications  

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma — Faculty Presentation 1: Optimizing the Current Management of Multiple Myeloma (MM) — Dr Joseph Mikhael CME information and select publications

Featuring perspectives from Drs Joseph Mikhael and Ajay Nooka, including the following topics: Introduction (0:00) Front-Line Treatment; Autologous Stem Cell Transplant (11:36) Use of Anti-CD38 Antibodies (29:36) CAR T-Cell Therapy (38:16) Treatment with Bispecific Antibodies (48:59) Other Treatments for Relapsed/Refractory Disease (56:07) CME information and select publications

Featuring perspectives from Drs Erica Mayer and Ruth O'Regan, including the following topics: Pregnancy during adjuvant endocrine therapy; fertility issues (0:00) Genomic biomarkers in the adjuvant setting (16:28) CDK4/6 inhibitors in metastatic disease (31:58) Adjuvant use of CDK4/6 inhibitors (47:42) Novel agents in metastatic disease (1:14:26) CME information and select publications

Featuring a slide presentation and related discussion from Professor Giuseppe Curigliano, including the following topics: Recent data with targeted therapies for patients with HER2-positive metastatic breast cancer (0:00) Case: A woman in her early 40s with a new right breast tumor 10 years after adjuvant radiation and endocrine therapy (17:17) Case: A woman in her mid 20s with a family history of...

Featuring an interview with Professor Giuseppe Curigliano, including the following topics: Vision for treating and curing HER2-positive metastatic breast cancer (mBC) in the future (0:00) Optimal treatment of HER2-positive mBC with brain metastases (7:42) Screening for and management of T-DXd-related interstitial lung disease (17:32) Gastric toxicities associated with the tucatinib/trastuzumab/cap...

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer — Faculty Presentation 2: Therapeutic Approaches for Patients with Other Actionable Genomic Alterations — Dr Gregory Riely CME information and select publications